Drinking straws are one of the tools in columnist Dagmar Munn's arsenal to combat dysphagia while living with ALS.

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...

Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform ...

Woolsey received three new U.S. patents covering innovations related to ROCK inhibitor Bravyl (oral fasudil), its ...

Taking short breaks from caregiving to enjoy time with her community in nature is a way to feed the soul, says columnist.

Neurosense Therapeutics will meet with the FDA in early November to discuss plans for a Phase 3 trial to test PrimeC in ALS.

Signs of angels come at the most unexpected — yet vital — moments in our lives, columnist Juliet Taylor writes.

A combined analysis of data over years in patients in Phase 2 trials of supports benefits for those up to age 65 and moderate ...

Columnist Kristin Neva is hopeful her nights won't be so hard, now that her husband with ALS can sleep a longer time on his back.

Columnist Dagmar Munn describes the frequent sensation of humming, which was among the early symptoms of her ALS.